PRAC meeting highlights 01 - 04 September 2025

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the September 2025 meeting are now available on the EMA website